Literature DB >> 25117711

Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage.

Laura A Tollini1, Aiwen Jin2, Jikyoung Park2, Yanping Zhang3.   

Abstract

Mdm2 E3 ubiquitin ligase-mediated p53 degradation is generally accepted as the major mechanism for p53 regulation; nevertheless, the in vivo significance of this function has not been unequivocally established. Here, we have generated an Mdm2(Y487A) knockin mouse; Mdm2(Y487A) mutation inactivates Mdm2 E3 ligase function without affecting its ability to bind its homolog MdmX. Unexpectedly, Mdm2(Y487A/Y487A) mice were viable and developed normally into adulthood. While disruption of Mdm2 E3 ligase function resulted in p53 accumulation, p53 transcriptional activity remained low; however, exposure to sublethal stress resulted in hyperactive p53 and p53-dependent mortality in Mdm2(Y487A/Y487A) mice. These findings reveal a potentially dispensable nature for Mdm2 E3 ligase function in p53 regulation, providing insight that may affect how this pathway is targeted therapeutically.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25117711      PMCID: PMC4369778          DOI: 10.1016/j.ccr.2014.06.006

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  59 in total

1.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

Authors:  Koji Itahana; Krishna P Bhat; Aiwen Jin; Yoko Itahana; David Hawke; Ryuji Kobayashi; Yanping Zhang
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

2.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

3.  Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.

Authors:  Jayne M Stommel; Geoffrey M Wahl
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

4.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

5.  Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity.

Authors:  Davide Danovi; Erik Meulmeester; Diego Pasini; Domenico Migliorini; Maria Capra; Ruth Frenk; Petra de Graaf; Sarah Francoz; Patrizia Gasparini; Alberto Gobbi; Kristian Helin; Pier Giuseppe Pelicci; Aart G Jochemsen; Jean-Christophe Marine
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

6.  Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts.

Authors:  Simona Parrinello; Enrique Samper; Ana Krtolica; Joshua Goldstein; Simon Melov; Judith Campisi
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

7.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.

Authors:  J D Oliner; J A Pietenpol; S Thiagalingam; J Gyuris; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

8.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

9.  Unravelling mechanisms of p53-mediated tumour suppression.

Authors:  Kathryn T Bieging; Stephano Spano Mello; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  38 in total

1.  SCFFBXO22 targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis.

Authors:  Jin Bai; Kenneth Wu; Meng-Han Cao; Yingying Yang; Yu Pan; Hui Liu; Yizhou He; Yoko Itahana; Lan Huang; Jun-Nian Zheng; Zhen-Qiang Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

2.  MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner.

Authors:  Boya Liu; Jingjie Yi; Xin Yang; Lu Liu; Xinlin Lou; Zeyuan Zhang; Hao Qi; Zhe Wang; Junhua Zou; Wei-Guo Zhu; Wei Gu; Jianyuan Luo
Journal:  Oncogene       Date:  2018-12-07       Impact factor: 9.867

Review 3.  Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Authors:  Erika Vacchelli; Norma Bloy; Fernando Aranda; Aitziber Buqué; Isabelle Cremer; Sandra Demaria; Alexander Eggermont; Silvia Chiara Formenti; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

4.  Dysfunction of the MDM2/p53 axis is linked to premature aging.

Authors:  Davor Lessel; Danyi Wu; Carlos Trujillo; Thomas Ramezani; Ivana Lessel; Mohammad K Alwasiyah; Bidisha Saha; Fuki M Hisama; Katrin Rading; Ingrid Goebel; Petra Schütz; Günter Speit; Josef Högel; Holger Thiele; Gudrun Nürnberg; Peter Nürnberg; Matthias Hammerschmidt; Yan Zhu; David R Tong; Chen Katz; George M Martin; Junko Oshima; Carol Prives; Christian Kubisch
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

5.  Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice.

Authors:  Hui Tian; Nicole R Tackmann; Aiwen Jin; Junnian Zheng; Yanping Zhang
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

6.  Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.

Authors:  Michael I Carr; Stephen N Jones
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

7.  Novel insights about the MDM2/MDM4 heterodimer.

Authors:  Fabiola Moretti
Journal:  Mol Cell Oncol       Date:  2015-08-20

8.  Characterization of cancer-associated missense mutations in MDM2.

Authors:  Krishna M Chauhan; Gopalakrishnan Ramakrishnan; Madhusudhan Kollareddy; Luis A Martinez
Journal:  Mol Cell Oncol       Date:  2015-12-10

9.  Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis.

Authors:  Michael I Carr; Justine E Roderick; Hugh S Gannon; Michelle A Kelliher; Stephen N Jones
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

10.  miR-579-3p controls melanoma progression and resistance to target therapy.

Authors:  Luigi Fattore; Rita Mancini; Mario Acunzo; Giulia Romano; Alessandro Laganà; Maria Elena Pisanu; Debora Malpicci; Gabriele Madonna; Domenico Mallardo; Marilena Capone; Franco Fulciniti; Luca Mazzucchelli; Gerardo Botti; Carlo M Croce; Paolo Antonio Ascierto; Gennaro Ciliberto
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.